Thyrocare Technologies informs about conference call

13 Feb 2018 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Thyrocare Technologies has informed about a transcript of the conference call held to discuss the Companys unaudited financial results for Quarter/Nine Months ended December 31, 2017, on Friday, February 09, 2018 at 02.30 pm local time. Velumani A., Ph.D., CEO, A. Sundararaju, CFO, Sachin Salvi, GM-Finance and Vatsal Goyal, Head-Strategy & Corporate Development, represented the Company.

The above information is a part of company’s filings submitted to BSE.

Thyrocare Tech. Share Price

922.20 -26.85 (-2.83%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7000.00
Max Healthcare Inst 1008.35
Narayana Hrudayalay 1265.30
Aster DM Healthcare 442.70
Global Health 1105.25
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.